Quantum-Si (NASDAQ:QSI – Get Free Report) had its price target increased by research analysts at HC Wainwright from $4.00 to $5.50 in a report released on Thursday,Benzinga reports. The firm presently has a “buy” rating on the stock. HC Wainwright’s price target suggests a potential upside of 295.68% from the stock’s current price. HC Wainwright also issued estimates for Quantum-Si’s Q4 2024 earnings at ($0.18) EPS, FY2024 earnings at ($0.65) EPS, Q1 2025 earnings at ($0.18) EPS, Q2 2025 earnings at ($0.17) EPS, Q3 2025 earnings at ($0.17) EPS, Q4 2025 earnings at ($0.17) EPS, FY2025 earnings at ($0.69) EPS, FY2026 earnings at ($0.56) EPS, FY2027 earnings at ($0.42) EPS and FY2028 earnings at ($0.22) EPS.
Separately, Canaccord Genuity Group decreased their price target on shares of Quantum-Si from $1.50 to $1.00 and set a “hold” rating for the company in a report on Wednesday, November 13th.
Read Our Latest Stock Analysis on QSI
Quantum-Si Trading Up 119.6 %
Institutional Inflows and Outflows
A number of institutional investors have recently added to or reduced their stakes in QSI. Jacobs Levy Equity Management Inc. acquired a new position in shares of Quantum-Si during the first quarter valued at $998,000. Vanguard Group Inc. increased its stake in shares of Quantum-Si by 1.6% in the first quarter. Vanguard Group Inc. now owns 5,300,685 shares of the company’s stock valued at $10,442,000 after purchasing an additional 82,463 shares during the period. Virtu Financial LLC bought a new stake in shares of Quantum-Si during the first quarter valued at approximately $98,000. Public Employees Retirement System of Ohio acquired a new position in shares of Quantum-Si during the first quarter worth approximately $27,000. Finally, SG Americas Securities LLC acquired a new stake in Quantum-Si in the 3rd quarter valued at approximately $53,000. 39.90% of the stock is currently owned by institutional investors.
About Quantum-Si
Quantum-Si incorporated, a life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS). The company's platform is comprised of the Platinum NGPS instrument; the Platinum Analysis Software service; and reagent kits and semiconductor chips for use with its instruments.
Recommended Stories
- Five stocks we like better than Quantum-Si
- Industrial Products Stocks Investing
- Why SoundHound AI Could Be the Next AI Powerhouse
- What is a buyback in stocks? A comprehensive guide for investors
- Lowe’s Stock Dip: Don’t Miss This Second-Chance Entry Point
- Quiet Period Expirations Explained
- Tailwinds Drive Walmart Higher, Uptrend Shows No Signs of Slowing
Receive News & Ratings for Quantum-Si Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quantum-Si and related companies with MarketBeat.com's FREE daily email newsletter.